Massachusetts Financial Services’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,384
Closed -$295K 869
2023
Q4
$295K Buy
+4,384
New +$305K ﹤0.01% 819
2023
Q3
Sell
-2,649
Closed -$244K 859
2023
Q2
$244K Sell
2,649
-5
-0.2% -$445 ﹤0.01% 808
2023
Q1
$275K Sell
2,654
-189
-7% -$20.9K ﹤0.01% 825
2022
Q4
$328K Buy
+2,843
New +$331K ﹤0.01% 830
2022
Q2
Sell
-1,688
Closed -$288K 869
2022
Q1
$288K Sell
1,688
-1,728
-51% -$326K ﹤0.01% 846
2021
Q4
$715K Sell
3,416
-4,855
-59% -$1M ﹤0.01% 836
2021
Q3
$1.59M Buy
8,271
+3,108
+60% +$764K ﹤0.01% 803
2021
Q2
$1.46M Buy
5,163
+2,998
+138% +$812K ﹤0.01% 810
2021
Q1
$459K Sell
2,165
-258
-11% -$61.7K ﹤0.01% 886
2020
Q4
$476K Buy
+2,423
New +$428K ﹤0.01% 840
2013
Q3
Sell
-21,590
Closed -$556K 841
2013
Q2
$556K Buy
+21,590
New +$567K ﹤0.01% 765

Other funds holding MED

Massachusetts Financial Services's MED Position: Q1 2024 in Review

Massachusetts Financial Services sold out of Medifast (MED) in Q1 2024, closing a stake of 4,384 shares — an estimated $295K sold.

Massachusetts Financial Services first reported a position in MED in Q2 2013 and held it in 11 quarters. The position peaked at $1.59M in Q3 2021. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Massachusetts Financial Services reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 4,384 Medifast shares in Q1 2024, an estimated $295K.
  • Massachusetts Financial Services first reported a position in Medifast in Q2 2013 and held it in 11 quarters.
  • Massachusetts Financial Services's Medifast position peaked at $1.59M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Massachusetts Financial Services's 13F filing for Q1 2024, filed 14 May 2024.